News
Oprah Winfrey and Elon Musk endorsed it. And though Indian celebrities haven’t yet admitted to their use, the mystery slimming of Bollywood filmmaker Karan Johar and TV talk show host Kapil Sharma ...
19hon MSN
Scientists have discovered novel drug candidates which could ultimately lead to new effective treatments for conditions ...
Rochelle McDonald has just been through the messiest of break-ups. “Guzman y Gomez were devastated,” she says, but 17 kilos ...
13d
American Woman on MSNWhere to Buy the Best USA Made Peptides in 2025?Peptides are gaining a lot of attention in various fields of research- medicine, biology, and cosmetics sciences- much i ...
15d
India Today on MSNWegovy weight-loss drug now in India: How it works and who should take itNovo Nordisk has introduced Wegovy, a once-weekly weight loss injection, in India. The drug aims to manage obesity and reduce ...
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
6d
The Print on MSNObesity care in India is evolving—no longer just diets & surgery, it’s all about multi-specialty approachAs obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised ...
18d
MedPage Today on MSNNovel Oral GLP-1 Agent Cuts A1c, Weight in Early DiabetesAn investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with early-stage type 2 diabetes, a phase III randomized trial found. Among 559 ...
Investing.com -- Bank of America (NYSE: BAC) has unveiled its top 10 U.S. Ideas for the third quarter of 2025, featuring eight Buy-rated stocks and two Underperform calls across ten industries.
Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. While Novo lost share to Eli Lilly's once-weekly Trulicity, Ozempic and Rybelsus ...
A blockbuster diabetes and weight-loss drug might be doing more than controlling blood sugar—it could also be protecting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results